Food Amino Acids Market Competitive Growth Strategies Based on Type, Applications, End User and Region

The global food amino acids market size is expected to reach US$ 9.8 Bn by the end of 2029. According to a study by Future Market Insights (FMI), the market will show a steady rise at 6.2% CAGR between 2019 and 2029. According to the report, the increase in demand for amino acids for various nutraceutical and dietary supplements, owing to the health benefits offered by amino acids, is expected to fuel the demand for amino acids during the review period. The report offers a comprehensive overview of the market, covering key growth drivers, restraints, opportunities, and prevailing trends. It uses unique research methods to offer the most accurate analysis of the market.

It includes in-depth insights into the food amino acids market. Some of these are:

  • The estimated value of the market was at US$ 5.4 Bn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
  • Asia-Pacific region holds the largest market share followed by North America.
  • The demand for dietary supplements has been increasing at a high pace among the consumers owing to the rising health awareness and increasing geriatric population in the developed economies.
  • The nutraceuticals and dietary supplements is estimated to dominate the global market.
  • The infant formula segment is projected to have the highest growth rate during the forecast period followed by the convenience foods segment.

Request a report sample to gain comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11235

“The demand for amino acids as functional foods, coupled with the rising acceptance of glutamic acid as a flavour enhancer in various foods and drinks, is likely to fuel market growth in the coming years,” said a lead analyst at FMI.

food amino acid regional assessment pr

Consumption of Dietary Supplements Likely to Increase as Consumers Look for Healthier Food Following Coronavirus Outbreak

When it comes to dietary supplements, protein stays in the top position; and amino acids are known as the building blocks of protein production. Amino acids in the human diet have been found to have several practical benefits. Glycine, for example, has been shown to enhance the quality of sleep; and leucine, for its role in muscle protein synthesis, thereby leading to longer and healthier life expectancy in the elderly.

The rise in international sporting activities has also led to increased attention being paid to the physiological effects of amino acids (BCAAs) on muscles, which is likely to provide a future market for manufacturers of amino acid ingredients. Product demand for pharmaceutical applications is projected to increase, enabling growth in the market. In addition to greater consumer buying power their focus on health and wellness as a result of the spread of coronavirus will augur well for the market.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-11235

Increasing demand for sweeteners is expected to boost demand for L-aspartic acid and phenylalanine from processed foods and ready-to-drink beverages. The emergence of microfiltration processes to increase yield is expected to provide lucrative opportunities for participants in the industry.

Who is Winning?

Some of the leading players operating in the food amino acids market are Kraemer Martin GmbH (Azelis), Pacific Rainbow International, Inc., CJ Corporation, Taiyo International, Monteloeder S.L., Sunrise Nutrachem Group, Kingchem LLC , Amino GmbH, Rochem International Inc., Brenntag AG, Pangaea Sciences Inc., Hugestone Enterprise Co., Ltd., Shaoxing Yamei Biotechnology Co., Ltd , Qingdao Samin Chemical Co., Ltd. , Daesang Corporation , Sigma-Aldrich, Prinova Group LLC , Evonik Industries , Ajinomoto Co., Inc., and Kyowa Hakko Kirin Group.

Via new product releases, acquisitions and investments, and agreements these businesses have improved their market position. Additionally, mergers and acquisitions continue to be a common strategy among market players. With strategic partnerships corporations plan to extend their global footprint. Methods of the biotechnology are commonly used in amino acid processing. Despite the fact that some of the amino acids cannot be produced cost effectively via biotechnology, it plays a significant role in the production of amino acids. Companies are investing in R&D activities to produce amino acid through biotechnology.

Get Valuable Insights into Food Amino Acids Market

Future Market Insights, in its new report, presents an unbiased analysis of the global food amino acids market, covering historical demand data and forecast figures for the period between 2019 and 2029. The study divulges compelling insights into growth witnessed in the market. Based on type, the market is segmented into glutamic acid, lysine, methionine, phenylalanine, tryptophan, and others. On the basis of application, the market has been segmented into nutraceuticals & dietary supplements, infant formula, food fortification, convenience foods, and others. On the basis of livestock, the global market is segmented into plant-based food, animal-based food, and synthetic. Regionally, the market can be segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

Medical Robots Market Insights, Deep Analysis of Key Vendor in the Industry 2026

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Medical Robots Market over the Assessment Period (2021-2031)

Future Market Insight’s (FMI’s) latest study published on the Medical Robots market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Medical Robots market.

As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Medical Robots market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Medical Robots market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

“To remain ‘ahead’ of your competitors, request for a sample” https://www.futuremarketinsights.com/reports/sample/rep-gb-1181

Advent of Telehealth and Virtual Care to Create Tailwind for the Medical Robots Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Medical Robots market.

Key Medical Robots Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Medical Robots market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1181

Report Benefits & Key Questions Answered

Medical Robots Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Medical Robots market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Medical Robots Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Medical Robots market. As per the survey, Medical Robots sales will project steady growth over the forecast period.

Medical Robots Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Medical Robots market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Medical Robots Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Medical Robots Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Medical Robots market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Medical Robots market.

Medical Robots Market: Key players

Some of the key players in Market are Stryker Corporation, Intuitive Surgical, Inc., Houston Medical Robotics, Inc., Hansen Medical, Inc., Kirbey lester, Otto Bock Healthcare, Kinova robotics, Varian Medical Systems, Hocoma AG, Vecna Robotics, Globus Medical, IRobot Corporatin, Titan Medical, Inc, KB Medical S.A.
Medical Robots Demand Analysis by Category
Global Medical Robots by Products:

Instruments and Accessories
Robotic Systems
Surgical Robots
Neurological Surgery Robotic Systems
Cardiology Surgery Robotic Systems
Laparoscopic Surgical Robotic Systems
Orthopaedic Surgical Robotic Systems
Steerable Robotics
Rehabilitation Robots
Therapeutic Robots
Prosthetic Robots
Assistive Robots
Exoskeleton Robots
Non-invasive Radiosurgery Robots
Hospital and Pharmacy automation robots
Pharmacy automation robots
IV Robots
Global Medical Robots Market, by Application

Neurology Applications
Orthopaedic Applications
Cardiology Applications
Laparoscopic Applications
Other Applications

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1181

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Topical Antibiotic Pharmaceuticals Market Trends, Key Driven Factors, Region-wise Outlook, Segmentation And Forecast To 2016 -2026

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Topical Antibiotic Pharmaceuticals Market over the Assessment Period 2016 -2026

Future Market Insight’s (FMI’s) latest study published on the Topical Antibiotic Pharmaceuticals market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Topical Antibiotic Pharmaceuticals market.

As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Topical Antibiotic Pharmaceuticals market is projected to witness robust growth during the forecast year 2016 -2026. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Topical Antibiotic Pharmaceuticals market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

“To remain ‘ahead’ of your competitors, request for a sample” https://www.futuremarketinsights.com/reports/sample/rep-gb-1441

Advent of Telehealth and Virtual Care to Create Tailwind for the Topical Antibiotic Pharmaceuticals Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Topical Antibiotic Pharmaceuticals market.

Key Topical Antibiotic Pharmaceuticals Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Topical Antibiotic Pharmaceuticals market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1441

Report Benefits & Key Questions Answered

Topical Antibiotic Pharmaceuticals Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Topical Antibiotic Pharmaceuticals market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Topical Antibiotic Pharmaceuticals Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Topical Antibiotic Pharmaceuticals market. As per the survey, Topical Antibiotic Pharmaceuticals sales will project steady growth over the forecast period.

Topical Antibiotic Pharmaceuticals Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Topical Antibiotic Pharmaceuticals market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Topical Antibiotic Pharmaceuticals Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Topical Antibiotic Pharmaceuticals Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Topical Antibiotic Pharmaceuticals market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Topical Antibiotic Pharmaceuticals market.

Topical Antibiotic Pharmaceuticals Market: Key Players

Major key players in global topical antibiotic pharmaceuticals market are Teva Pharmaceuticals, Perrigo, Taro Pharmaceuticals, Pfizer, Glenmark Pharmaceuticals, GlaxoSmithKline, Fougera, and Dynarex.

Topical Antibiotic Pharmaceuticals Demand Analysis by Category
Based on the product type, the global topical antibiotic pharmaceuticals market is segmented into the following:

Creams
Ointments
Powders
Suspensions
Emulsions
Based on the type end user, the global topical antibiotic pharmaceuticals market is segmented into the following:

Hospitals Clinics
Private Clinics
Retail Pharmacies and Drug Stores
E-commerce

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1441

Region
North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Computed Tomography Market Key Players, SWOT Analysis, Key Indicators and Forecast to 2025

Future Market Insights (FMI), a Leading Market Research and Competitive Intelligence Provider Offers Exhaustive Analysis on Key Factors Burgeoning the Sales in the Global Computed Tomography Market over the Assessment Period (2021-2031)

Future Market Insight’s (FMI’s) latest study published on the Computed Tomography market provide insights into key factors uplifting the sales over the next ten years. It provides unbiased analysis on key trends, drivers, and opportunities across key segments, the report also provides strategic analysis on the incumbents, existing players, and leading players operating in the Computed Tomography market

As per comprehensive research conducted by ESOMAR-certified consulting firm FMI, the global Computed Tomography market is projected to witness robust growth during the forecast year 2021-2031. The report emphasizes on providing key insights into diverse features including demand, product developments, revenue generation, and sales in the Computed Tomography market.

The study offers a detailed analysis of dynamics including driver, restraints, opportunities, and challenges, and also highlights their consequent impact on the market.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-860

Advent of Telehealth and Virtual Care to Create Tailwind for the Computed Tomography Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Computed Tomography market.

Key Computed Tomography Market Takeaways and Projections

The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
Germany Computed Tomography market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-860

Report Benefits & Key Questions Answered

Computed Tomography Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Computed Tomography market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
Computed Tomography Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Computed Tomography market. As per the survey, Computed Tomography sales will project steady growth over the forecast period.

Computed Tomography Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Computed Tomography market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
Computed Tomography Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
Computed Tomography Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Computed Tomography market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Computed Tomography market.

Computed Tomography Market: Key Players

Some of the key market players in global computed Tomography market are GE Health Care, Siemens Health Care and Toshiba Medical System Corporation, Philips Health Care, Hitachi Medical Corp, Neusoft Medicals, Neurologica Company Ltd.

Computed Tomography Demand Analysis by Category
By Product:

Low Slice CT Scanner (64 slices)

By Application:

Cardiovascular Applications
Oncology
Neurovascular Application
Abdomen and Pelvic Application
Pulmonary Angiogram
Spinal Application
Musculoskeletal Application

By End Users:

Diagnostic Centers
Hospitals

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-860

Region

North America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Dental X-ray Systems Market will grow at a striking CAGR of over 6% by the end of 2026

Increasing incidences of acute diseases like cancer has created a robust demand for effective diagnostics and treatment for the early detection of this disease and increase the probability of survival. As a result, dental X-ray systems have witnessed a rapid rise in their demand, on the back of their qualification as a promising diagnostics and treatment procedure. In addition to this, the dental X-ray systems significantly reduce the radiation dose among the patients, which strengthens the trust of the medical practitioners in the equipment and boosts the growth of the dental X-ray systems market.

Rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. According to a report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by the portable intraoral X-ray systems, the traditionally used floor mounted dental X-ray systems are gradually becoming obsolete. When weighted on the basis of cost, dental X-ray systems provides far better affordability to the dental clinics and hospitals as compared to the cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-8960

Challenges Pertaining to the Dental X-ray Systems Market: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Dental X-ray Systems Market

Innovations and advancements brought about in the medical imaging vicinity and especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of the diseases, which has been fulfilled by the dental X-ray systems. Given the multifold applications of these systems, the global dental X-ray systems market is projected to grow exponentially.

North America to Maintain a Strong Hold on the Global Dental X-ray Systems Market

The study on dental X-ray systems market provides a detailed analysis on the basis of several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to the advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8960

Collaboration and Mergers to Trigger the Growth of the Dental X-ray Systems Market

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market.

The leading players incorporated in the report are

FONA, J.

MORITA CORP.,

Danaher Corporation,

PLANMECA OY,

Prexion Corporation,

Carestream Dental,

LLC,

Owandy Radiology,

Vatech Co. Ltd.,

The Yoshida Dental Mfg. Co. Ltd.,

Dentsply Sirona,

LED Medical Diagnostics Inc.,

Cefla S.C., and Air Techniques, Inc., among others.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8960

Key Segment

Based on the product type

Cephalometric Projections Systems

Portable Intraoral X-ray Systems

Panoramic X-ray Systems

Intraoral X-ray Systems Mounted on the Floor

Based on the geographies

North America

Europe

Latin America

Middle East & Africa (MEA)

China

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Medical Nitroglycerin Sprays Market expected to register a CAGR of 4.2% during the forecast period, reaching US$ 147.3 Million by the end of 2030

In a recent study, Future Market Insights (FMI) has forecast the medical nitroglycerin spray market to record consistent growth between 2020 and 2030. The report also projects the market to reach a valuation of US$147.3 Mn by the end of 2030.

Rising prevalence of cardiovascular ailments around the world have led to significant developments in cardiac treatments. Among those, heightening adoption of nitroglycerin sprays is touted as one of the most renowned treatment approaches.

Coronary heart disease is among the leading causes of morbidity and fatality amongst heart patients. This disease is the leading cause of angina pectoris, or acute chest pain, caused due to blockage of arteries. To offset the discomfort, adoption of nitroglycerin sprays is rising significantly.

A significant proportion of the global heart ailment population remain undiagnosed for angina pectoris. According to FMI, this undiagnosed population base is what would possible heighten growth prospects for the market across the upcoming forecast decade.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-12620

Key Takeaways from the Medical Nitroglycerin Sprays Study

North America touted to retain market hegemony, capturing over two-fifths of the revenue share

Prophylaxis of angina pectoris to remain the dominant segment, expanding steadily at 4.1% CAGR from 2020-2030

By distribution channel, online pharmacy sales are poised to witness credible expansion owing to the pandemic and deepening digital literacy

90 metered sprays/bottle dose capacity to remain the most preferred option, registering an index of 1.4

Global medical nitroglycerin sprays market is likely to expand steadily, registering a CAGR of 4.2%

“Continued innovations in product development to roll out effective therapeutic options for angina pectoris treatment characterize vendors’ principal expansion strategies,” concludes the FMI analyst.

COVID-19 Impact Insights

The COVID-19 pandemic has had detrimental impacts on the world at large, bringing in massive revenue shortfalls and reduced profit margins. A long-term economic recession is likely to be perpetuated for the forthcoming years.

With regard to nitroglycerin sprays, the market is expected to decelerate in the professional caregiving sector, attributed to shifting priorities towards the pandemic’s eradication. Therefore, elective surgeries for cardiac diseases are being postponed, leading to limited uptake of nitroglycerin sprays.

This deferment of elective cardiovascular surgeries is prompting patients to opt for homecare alternatives. Consequently, oral and sublingual administration of nitroglycerin sprays has been rising steadily to prevent acute angina attacks.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12620

Competitive Intelligence

The global medical nitroglycerin sprays market is highly consolidated, with the presence of four prominent players:

Perrigo Company Plc.,

Evus Health Solutions LLC., G.

Pohl-Boskamp GmbH & Co. and

Akrimax Pharmaceuticals LLC.

These players primarily concentrate on portfolio strengthening by introducing new products into the market.

For instance, in September 2020, Perrigo Company Inc. introduced the store brand equivalent of Voltaren® Arthritis Pain Reliever in over-the-counter pharmacy stores. It is the first abbreviated new drug application (ANDA) to receive U.S FDA approval.

In 2006, Evus Health Solutions received clearance from the FDA to launch the NitroMist® Nitroglycerin Lingual Aerosol Spray. The device is a nitrate vasodilator indicated for acute relief of an attack or acute prophylaxis of angina pectoris. This 400 mcg per spray is available in 230 metered or 90 metered sprays per container.

G-Pohl-Boskamp GmbH & Co. is one of Germany’s most successful independent pharmaceutical producers. Its product portfolio includes a range of products for several chronic conditions. In this case, the company manufactures the Nitrolingual Pumpspray available in 60 and 200 metered sprays per container.

More Insights on the Medical Nitroglycerin Sprays Market

Future Market Insights provides an unbiased global industry analysis (2015-2019) and opportunity assessment (2020-2030) on the medical nitroglycerin sprays market. The report provides compelling insights on basis of application (prophylaxis of angina pectoris & acute relief of attack (treatment)), dose capacity (60 metered spray/bottle, 90 metered sprays/bottle, 200 metered sprays/bottle, 230 metered sprays/bottle), and distribution channel (hospital pharmacies, retail pharmacies and online pharmacies) across seven major regions.

Medical Nitroglycerin Sprays Market- Segmental Overview

Application

Prophylaxis of Angina Pectoris

Acute Relief of Attack (Treatment)

Dose Capacity

60 metered sprays/bottle

90 metered sprays/bottle

200 metered sprays/bottle

230 metered sprays/bottle

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12620

Region

North America (U.S & Canada)

Latin America (Brazil, Mexico, Argentina & Rest of Latin America)

Europe (Germany, Italy, France, U.K, Spain, BENELUX, Russia & Rest of Europe)

East Asia (China, Japan & South Korea)

South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)

Oceania (Australia & New Zealand)

Middle East & Africa (GCC, South Africa, Northern Africa & Rest of MEA)

Electronic Medical Records (EMR) Market to Reach US$ 21.5 Billion, Globally, by 2031 at 7.8% CAGR: FMI

Future Market Insights (FMI) in its latest market report states that electronic medical records (EMR) market is poised to expand at 7.8% CAGR through the forecast period 2021-2031. EMR market experienced significant growth in 2021 due to pandemic and increased burden on healthcare system.

EMR market registered 5.5% year-on-year growth rate in 2021 and is estimated to surpass the valuation of US$ 21.5 Billion by the end of 2021.

Increasing government support for implementation of EMR in U.S. under the Health Information Technology for Economic and Clinical Health (HITECH) Act is acting as a key factor driving the demand for EMR in the region.

Also, steps taken by various governments to encourage digital transformation in healthcare will bode well for the market. EMR deployment will therefore rise as policies are implemented to health healthcare systems go paperless by completely digitizing the medical records.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-387

In June 2021, under government of U.K., NHS Digital’s Terminology Server went live enabling the healthcare IT system to collaborate with multiple healthcare facilities while transitioning medical reports and data.

Surge in number of ailments in children and infants and rising necessity to create reliable appointment charts for children and parenting will accelerate the demand for EMR. Increasing incorporation of EMR at various phases of clinical trials and use of web applications in EMR management will drive the market for electronic medical records (EMR).

However, high cost of digitizing EMR is a growing concern as it increases healthcare cost. Rising government funding and increasing spending power of customers will boost the market growth.

Key Takeaways from FMI’s Electronic Medical Records (EMR) Market Study

North America electronic medical records (EMR) market is forecast to grow at 8.2% CAGR during the assessment period backed by stringent data protection laws, favorable insurance policies and thriving healthcare industry in U.S. and Canada.

Due to rising demand for better patient experience and digitization of medical records in U.K and Germany, Europe EMR market will expand at 7.5% CAGR during the forecast period.

Australia is forecast to exhibit tremendous growth owing to increased government spending on integrating artificial intelligence with electronic health report solutions and development of unified EMR service for easy access of patient’s medical details from anywhere in the country.

Japan is estimated to account for 31.5% of East Asia market share as of 2021. Increasing economic development and rising population will create lucrative opportunities for growth in East Asia.

Service based EMR are expected to showcase elevated demand and is forecast to hold more than 60.12% of global EMR market share throughout the assessment period.

The clinical segment of end use will experience tremendous and is expected to account for more than 27% of global market share by the end of 2031.

“With focus on digital transformation rising, EMR solution providers are likely to engage in strategic collaboration for knowledge sharing. The market is therefore slated to witness a spur of technological developments in the coming years, which will spur its growth,” says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-387

Who is Winning?

FMI identifies Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions Inc., GE Healthcare, McKesson Corporation, and NextGen Healthcare as the top EMR market players. They hold around 65% of global market share.

Market players are forming strategic partnership, merger, and acquisition to accelerate product development and strengthen their position in this high competitive market,

They are also involved in performing extensive research and development for product portfolio expansion. They are also working towards developing low cost EMR services to penetrate emerging economies.

MEDITECH launched a new genomic electronic medical and health record solutions in March 2021. The company claims that the new service will enhance the effectiveness of precision medicines by assisting user in handling complex genomic data.

In May 2021, Physician’s Computer Company (PCC) partnered with the Comprehensive Health and Decision Information System (CHADIS) with the aim to reduce hassle while accessing screenings for concerns like asthma, ADHD, depression, and even parenting.

Prominent players operating in the electronic medical records (EMR) market are:-

Cerner Corp

McKesson Corporation

Medical Information Technology Inc.

Epic Systems Corporation

NextGen Healthcare Information Systems LLC

Greenway Health LLC

GE Healthcare

Key Segments Covered in Electronic medical records (EMR) Market Study

By Product

Hospital

Ambulatory

By End Use

Hospitals

General Physician Clinics

Specialised Clinics

Ambulatory Surgical Centres

By Components

Software

Services

By Delivery Mode

Client Server Setups

Cloud-based Setups

Hybrid Setups

Region

North America

U.S.

Canada

Latin America

Brazil

Mexico

Rest of Latin America

Western Europe

U.K.

France

Germany

Spain

Italy

Rest of Western Europe

Eastern Europe

Russia

Poland

Rest of Eastern Europe

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-387

Asia Pacific Excluding Japan (APEJ)

Greater China

India

Australia and New Zealand

Rest of APEJ

Japan

Middle East & Africa

GCC

South Africa

Rest of MEA

PARP Inhibitors Market is estimated to be valued at US$ 8.4 Billion by 2026, expanding at a significant CAGR from 2021 to 2026

Rising burden of various types of cancers such as ovarian, breast, prostate, and pancreatic cancer is anticipated to generate significant demand for PARP inhibitors. According to the Global Cancer Observatory (GLOBOCAN), countries such as China, the U.S., India, and Japan, collectively diagnose over 120,000 new cases of ovarian cancer each year. The incidence of breast cancer is much higher in these countries, and with superior efficacy of PARP inhibitors as compared to other available cancer treatment options, the PARP inhibitors market is expected to gain significant revenue over the forecast period.

The global PARP inhibitors market is estimated to be valued at US$ 8.4 Bn by 2026, expanding at a significant CAGR from 2019 to 2026.

“The unique ability of PARP inhibitors to improve progression-free survival in ovarian and breast cancer patients is expected to generate extensive traction for the market, thereby propelling the growth of the global PARP inhibitors market over the forecast period.”

Key Takeaways of PARP Inhibitors Market Study

Olaparib, with various expanded approvals for the treatment of ovarian cancer, breast cancer, and pancreatic cancer, and rapid increase in potential patient pool, contributed to the dominance of the segment by drug in 2018, and will continue to do so during the forecast period.

PARP inhibitors are regarded as a new standard of care for ovarian cancer after first-line platinum chemotherapy. Adoption of PARP inhibitors for ovarian cancer treatment has surged, and the trend is expected to continue during the forecast period, owing to the ability of PARP inhibitors to induce ovarian cancer patients into remission for longer periods of time as compared to any other marketed therapy.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-3197

With a strong pipeline, significant number of PARP inhibitors are expected to go for approval through the new drug application (NDA) process and for expanded approval to treat various types of cancers.

Strategic Acquisitions & Collaborations by Key Players to Widen Regional Presence

All marketed PARP inhibitors are under patent, and with no generic launch in sight till 2027, the market is expected to remain consolidated till the second half of this decade. Key players in the PARP inhibitors market are undergoing major collaborative efforts, mergers, and acquisitions in order to expand their regional product offerings. For example, in January 2019, GlaxoSmithKline plc acquired TESARO Inc., an oncology-focused biopharmaceutical company with a marketed PARP inhibitor named Zejula (Niraparib).

More Valuable Insights on PARP Inhibitors Market

Future Market Insights brings a comprehensive research report on forecast revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2026. The global PARP inhibitors market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on PARP inhibitors market on basis of drug (Olaparib, Niraparib, Rucaparib, and Talazoparib), indication (ovarian cancer, breast cancer, prostate cancer, and pancreatic cancer), and distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies), across seven major regions.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3197

PARP INHIBITORS MARKET TAXONOMY

The global PARP inhibitors market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Drug

Olaparib

Niraparib

Rucaparib

Talazoparib

Indication

Ovarian Cancer

Breast Cancer

Prostate Cancer

Pancreatic Cancer

Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3197

Region

North America

Europe

Latin America

South Asia

East Asia

Oceania

Middle East And Africa

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Dengue Vaccine Market is poised to expand at a staggering double-digit CAGR through 2031, surpassing US$ 1 billion during the forecast period

The global dengue vaccines market is poised to expand at a staggering double-digit CAGR through 2031, surpassing US$ 1 billion during the forecast period, concludes ESOMAR-certified market research company Future Market Insights (FMI) in its recently published report. Growth is majorly underpinned by the rising incidence of dengue fever across endemic regions.

According to the World Health Organization, 70% of the total disease burden is prevalent across Asia, thereby encouraging prominent pharmaceutical giants to increase inroads across such countries as India, the Philippines and Japan. Presently, the market appears highly consolidated, attributed to the existence of just one effective vaccine candidate- Sanofi Pasteur’s Dengvaxia®.

However, future pipeline projects by other prominent giants is likely to enhance the scope of the market. For instance, since 2018, Sun Pharmaceuticals Ltd. is working on the DSV4 vaccine which is expected to provide protection against dengue infection to previously unaffected patients. Likewise, since 2017, the Serum Institute of India has been developing the VIS513 monoclonal antibody which have exhibited positive outcomes in neutralizing the dengue virus in animal mode studies, with a breakthrough expected in 2021.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Key Takeaways from FMI’s Dengue Vaccines Market Study

CYD-TDV (Dengvaxia) to retain its dominance in the global dengue vaccines market, alternative candidates are under investigation

By end-user, governments are expected to pivot majority of dengue vaccines demand in forthcoming years

Major pharmaceutical giants are concentrating on developing live attenuated dengue vaccines amid their perceived greater effectiveness

US to experience escalating growth, amid ongoing clinical trials to develop more vaccine candidates

Mexico is expected to emerge as an attractive destination for dengue vaccine manufacturers

Rising health & hygiene initiatives to spur dengue vaccines development across India

Brazil to pivot most of the Latin American dengue vaccine market, amid an extremely high prevalence rate

“Present dearth of multiple vaccine candidates is likely to generate credible opportunities for prominent pharmaceutical corporations to increase R&D funding for new clinical trials and licenses, leading to an expansion of the global dengue vaccines market,” says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1763

Competitive Landscape

Sanofi Pasteur Limited,

Takeda Pharmaceutical Company Limited,

Merck & Co. Inc.,

GlaxoSmithKline Plc,

GeneOne Life Science Inc.,

Medigen Vaccine Biologics Corporation,

Panacea Biotec Limited,

Sun Pharmaceutical Industries Ltd,

Serum Institute of India Pvt. Ltd.

Biological E Ltd.

are some prominent dengue vaccines manufacturers as profiled by FMI.

Prominent players are looking to constantly introduce new vaccine candidates in order to remain afloat in the market. In 2020, Medigen Vaccine Biologics Corporation (MVC) completed the phase II study for the TetraVax-DV dengue vaccine in Taiwan, thereby establishing the safety and efficacy of the candidate. It subsequently initiated phase III of the study.

Likewise, in September 2020, Panacea Biotec Limited completed of its Phase I/II study of its novel, tetravalent recombinant chimeric Dengue candidate vaccine christened DengiAll. After a single dose, over 80% of the participants exhibited more than a trivalent response and around 95% showed multivalent response.

More Insights on the Global Dengue Vaccines Market

In its latest report, FMI offers an unbiased analysis of the global dengue vaccines market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product (CYD-TDV (Dengvaxia)) and end-user (hospitals, government institutes and NGOs) across seven regions (North America, Latin America, APEJ, Western Europe, Eastern Europe, Middle East & Africa and Japan).

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1763

Key Segments Covered

Product

CYD-TDV (Dengvaxia)

End-User

Hospitals

Government Institutes

Non-governmental Organizations (NGOs)

Region

North America (US and Canada)

Latin America (Brazil, Mexico, Venezuela and Rest of LATAM)

Western Europe (Germany, UK, France, Spain, Italy and Rest of Western Europe)

Eastern Europe (Russia, Poland and Rest of Eastern Europe)

APEJ (The Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ)

Japan

Middle East & Africa (GCC, Northern Africa, South Africa and Rest of MEA)

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

Self-adhesive Tear Tape Market Size, Share, Trends, Application Analysis and Growth by Forecast to 2020-2030 | FMI

A recent study by ESOMAR-certified consulting firm Future Market Insights projects a positive outlook for the Self-adhesive Tear Tape market over the forecast period. The report gives a detailed outlook about the ongoing changes and advancement that are expected to augment growth in the Self-adhesive Tear Tape market. With a unique approach and extensive data analysis, FMI presents a detailed perspective on the market, key growth drivers, threats and challenges that market players are likely to face during the forecast period.

According to the study, the Self-adhesive Tear Tape market is expected to reach a valuation of US $185 at a CAGR of 5% over the forecast period. Technological advancements in the packaging industry across various verticals will enable growth in the market. Increasing investment in research and development activities and adoption of information technology within the industry, will create growth opportunities. FMI’s latest report gives significant details about the current and upcoming market scenario for an optimized assessment of the market.

Download Your Sample Copy of This Report https://www.futuremarketinsights.com/reports/sample/rep-gb-7831

COVID-19 Impact Analysis on Self-adhesive Tear Tape Market
Following the outbreak of COVID-19, the packaging industry is expected to witness a moderate growth after a steep fall. Soaring development in various sectors of packaging including the increased R&D activities from the prominent players has led the Self-adhesive Tear Tape market in the positive direction. Manufacturers are more focused on the sustainability as a key strategy to maintain their position in the industry during the time of crisis.

FMI provides an extensive information on growth strategies that will aid the players to tackle the impact of pandemic on the global Self-adhesive Tear Tape market. This detailed chapter will give the market players information on the market scenario following the outbreak of COVID-19 and its impact on the industry across major regions. With various info graphics and detailed data sets, the market players are provided with market intelligence solutions which are accurate, transparent and reliable for the upcoming decade.

Important Questions Answered in the Self-adhesive Tear Tape Market Report
• Which are the top companies operating in the Self-adhesive Tear Tape market?
• What will be the future outlook of the Self-adhesive Tear Tape market in the upcoming decade?
• What are the key growth drivers and restraints likely to affect the Self-adhesive Tear Tape market in the future?
• Which region is expected to be the most lucrative region for the Self-adhesive Tear Tape market?
• What are the ongoing trends likely to augment the growth of the global Self-adhesive Tear Tape market?
Why Choose Future Market Insights
• Serving domestic and international clients 24/7
• Strives to deliver optimized and accurate results
• Data collected from reliable primary and secondary sources
• Highly trained and experienced team of research analysts
• Deliver market reports with precision and diligence
Discounted prices for new customers! Offer expires soon!

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-7831

Self-adhesive Tear Tape Market: Segmentation
In-depth analysis on FMI’s Self-adhesive Tear Tape market report has been further classified into key segments and sub-segments.
By Width
• Up to 2.5 mm
• 2.6 mm to 5.0 mm
• Above 5.0 mm
By Material Type
• PP
o BOPP
o CPP
o MOPP
• PVC
• PET
• PE
• Others
By End Use
• Food
• Tobacco
• Pharmaceuticals
• Personal Care
• Electrical & Electronics
• Others (Agriculture, Logistics, etc.)
By Region
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa
Self-adhesive Tear Tape Market: Competitive Analysis
The latest report on the Self-adhesive Tear Tape market by FMI gives an unbiased analysis on the top 10 leading companies operating in the Self-adhesive Tear Tape market. It provides a detailed segmentation on the market players’ product launches, strategic mergers and acquisition and revenue prospects that will aid the players to gain a competitive edge in the industry.
Key players profiled by FMI in Self-adhesive Tear Tape market includes:
• Tann Germany GmbH,
• DS Smith Plc,
• Polinas Plastik Sanayi ve Ticaret A.S.,
• Septa GmbH,
• Anhui Eastern Communication Packing Material Co., Ltd
Significant Contributions to the Report
• Key Trends and Opportunities: Comprehensive analysis on the industries ongoing trends and opportunities for market players in different regions across the globe
• Recent Challenges and Forecasts: Detailed assessment on the challenges, technological advancements, and forecast for upcoming decade.
• Segmental Analysis: Extensive research on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
• Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions.